EUVIMEDEUVIMED entdecken
Übersichtsarbeit

FGFs, their receptors, and human limb malformations: Clinical and molecular correlations

Andrew O M Wilkie, Susannah J Patey, Shih-Hsin Kan, Ans M W van den Ouweland, Ben C J Hamel

American Journal of Medical Genetics · 15.10.2002 · 112 (3) · 266-278

DOI: 10.1002/ajmg.10775 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Medical Genetics, online erschienen am 27.08.2002. Verfasst von Andrew O M Wilkie und 4 weiteren Autor:innen. Beteiligte Einrichtung: Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom. awilkie@molbiol.ox.ac.uk. Die Arbeit wurde bisher 163-mal zitiert (Crossref) und nennt 89 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibroblast growth factors (FGFs) comprise a family of 22 distinct proteins with pleiotropic signaling functions in development and homeostasis. These functions are mediated principally by four fibroblast growth factor receptors (FGFRs), members of the receptor tyrosine kinase family, with heparin glycosaminoglycan as an important cofactor. Developmental studies in chick and mouse highlight the critical role of FGF‐receptor signaling in multiple phases of limb development, including the positioning of the limb buds, the maintenance of limb bud outgrowth, the detailed patterning of the limb elements, and the growth of the long bones. Corroborating these important roles, mutations of two members of the FGFR family ( FGFR1 and FGFR2 ) are associated with human disorders of limb patterning; in addition, mutations of FGFR3 and FGF23 affect growth of the limb bones. Analysis of FGFR2 mutations in particular reveals a complex pattern of genotype/phenotype correlation, which will be reviewed in detail. Circumstantial evidence suggests that the more severe patterning abnormalities are mediated by illegitimate paracrine signaling in the mesoderm, mediated by FGF10 or by a related FGF, and this is beginning to gain some experimental support. A further test of this hypothesis is provided by a unique family segregating two FGFR2 mutations in cis (S252L; A315S), in which severe syndactyly occurs in the absence of the craniosynostosis that typically accompanies FGFR2 mutations. © 2002 Wiley‐Liss, Inc.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcrocephalosyndactyliaAmino Acid SequenceAnimalsBody PatterningFemaleFibroblast Growth Factor-23Fibroblast Growth FactorsHumansLimb Deformities, CongenitalMaleMolecular Sequence DataMutationPedigreePhenotypeReceptor Protein-Tyrosine KinasesReceptor, Fibroblast Growth Factor, Type 2Receptors, Fibroblast Growth FactorSequence Homology, Amino AcidSignal TransductionSyndactyly

Substanzen

FGF23 protein, humanFgf23 protein, mouseReceptors, Fibroblast Growth FactorFibroblast Growth FactorsFibroblast Growth Factor-23FGFR2 protein, humanReceptor Protein-Tyrosine KinasesReceptor, Fibroblast Growth Factor, Type 2

Autor:innen und Institutionen

  • Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom. awilkie@molbiol.ox.ac.uk

Zitieren

APA

Wilkie, A. O., Patey, S. J., Kan, S. H., van den Ouweland, A. M., & Hamel, B. C. (2002). FGFs, their receptors, and human limb malformations: Clinical and molecular correlations. American Journal of Medical Genetics, 112(3), 266-278. https://doi.org/10.1002/ajmg.10775

Vancouver

Wilkie AO, Patey SJ, Kan SH, van den Ouweland AM, Hamel BC. FGFs, their receptors, and human limb malformations: Clinical and molecular correlations. American Journal of Medical Genetics. 2002;112(3):266-278. doi:10.1002/ajmg.10775

BibTeX
@article{Wilkie2002,
  author = {Wilkie, Andrew O M and Patey, Susannah J and Kan, Shih-Hsin and van den Ouweland, Ans M W and Hamel, Ben C J},
  title = {FGFs, their receptors, and human limb malformations: Clinical and molecular correlations},
  journal = {American Journal of Medical Genetics},
  year = {2002},
  volume = {112},
  number = {3},
  pages = {266--278},
  doi = {10.1002/ajmg.10775}
}
Kostenlos starten →